13 completed, 2 unknown, 1 not yet recruiting, 1 withdrawn. 17 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 17 | Completed 13, Unknown 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Alphavirus Infections: new trials by email Literature Review of Alphavirus Infections trials Research Report on Alphavirus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers V4020 - Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Not yet recruiting | Medigen, Inc. | 39 | 2025-08-15 | 2025-07-28 |
| Trial of an Inactivated Chikungunya Virus Vaccine HydroVax-005 CHIKV, Placebo - Chikungunya Fever, Chikungunya Virus | Phase 1 | Completed | Najit Technologies, Inc. | 48 | 2024-11-04 | 2026-03-19 |
| Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico. CHIK low dose, CHIK mid dose, CHIK high dose - Chikungunya, Zika | Phase 1 | Completed | University of Oxford | 120 | 2020-10-23 | 2022-03-23 |
| Phase 1 Study of SAR440894 vs Placebo Placebo, SAR440894 - Chikungunya Virus Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 42 | 2020-10-14 | 2026-01-13 |
| Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects MVA-BN-WEV Dose 1, MVA-BN-WEV Dose 2, MVA-BN-WEV Dose 3 - Equine Encephalitis | Phase 1 | Completed | Bavarian Nordic | 45 | 2019-10-07 | 2020-08-20 |
| VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults VRC-WEVVLP073-00-VP, VRC-GENMIX083-AL-VP - Venezuelan Equine Encephalitis, Western Equine Encephalitis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2019-04-02 | 2021-03-24 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults mRNA-1944, Placebo - Prevention of Chikungunya Virus Infection | Phase 1 | Completed | ModernaTX, Inc. | 39 | 2019-01-22 | 2021-07-07 |
| Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001) ChAdOx1 Chik - Chikungunya Fever | Phase 1 | Completed | University of Oxford | 24 | 2018-07-31 | 2019-10-18 |
| Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine Vaccinations on Day 0, Day 28, and Day 140 - Encephalitis, Encephalitis, Viral | Phase 1 | Unknown | SRI International | 48 | 2018-07-17 | 2021-02-23 |
| Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers VLA1553 - Chikungunya | Phase 1 | Completed | Valneva Austria GmbH | 120 | 2018-03-05 | 2019-08-29 |
| Phase I Trial of Measles Vectored Chikungungya Vaccine Placebo, VRC-CHKVLP059-00-VP - Chikungunya Virus Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 180 | 2017-05-30 | 2020-11-27 |
| Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine Inactivated Chikungunya virus vaccine 20 mcg, Inactivated Chikungunya virus vaccine 30 mcg, Inactivated Chikungunya virus vaccine 10 mcg - Chikungunya | Phase 1 | Completed | Bharat Biotech International Limited | 60 | 2017-04-17 | 2020-10-28 |
| Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins anti-CHIKV hyperimmune immunoglobulins - Chikungunya Virus Infection | Phase 1 / Phase 2 | Unknown | Centre Hospitalier Universitaire de la Guadeloupe | 40 | 2014-09-01 | 2014-11-03 |
| Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate, 0.9% saline placebo - Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Completed | Ichor Medical Systems Incorporated | 42 | 2013-12-01 | 2015-08-26 |
| Chikungunya Virus Vaccine Trial in Healthy Adults VRC-CHKVLP059-00-VP - Viral Vaccines, Chikungunya Fever | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 25 | 2011-12-01 | 2016-07-25 |
| Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine Formalin-treated, UV-inactivated, whole-virion, Vero cell-derived, preservative free Ross River Virus (RRV) vaccine with or without an Al(OH)3 adjuvant - Ross River Virus Disease (RRVD) | Phase 1 / Phase 2 | Completed | Alachua Government Services, Inc. | 400 | 2008-06-01 | 2015-10-09 |
| Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine VEE 3526 - Venezuelan Equine Encephalitis | Phase 1 | Withdrawn | DynPort Vaccine Company LLC, A GDIT Company | 2005-07-01 | 2015-09-18 |
Chikungunya Fever (10) · Encephalomyelitis, Venezuelan Equine (5) · Encephalomyelitis, Equine (2) · Virus Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Central Nervous System Viral Diseases (1) · Encephalitis (1) · Encephalitis, Viral (1) · Encephalomyelitis (1) · Encephalomyelitis, Eastern Equine (1) · Encephalomyelitis, Western Equine (1) · Infectious Encephalitis (1)
Arbovirus Infections (17) · Infections (17) · Mosquito-Borne Diseases (17) · Vector Borne Diseases (17) · RNA Virus Infections (16) · Togaviridae Infections (16) · Virus Diseases (15) · Encephalitis, Arbovirus (6) · Neuroinflammatory Diseases (6) · Brain Diseases (5) · Central Nervous System Diseases (5) · Central Nervous System Infections (5) · Central Nervous System Viral Diseases (5) · Encephalitis (5)
Vaccines (1) · aluminum sulfate (1)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · University of Oxford (2) · Alachua Government Services, Inc. (1) · Bavarian Nordic (1) · Bharat Biotech International Limited (1) · Centre Hospitalier Universitaire de la Guadeloupe (1) · DynPort Vaccine Company LLC, A GDIT Company (1) · Ichor Medical Systems Incorporated (1) · Medigen, Inc. (1) · ModernaTX, Inc. (1) · Najit Technologies, Inc. (1) · SRI International (1) · Valneva Austria GmbH (1)
United States (12) · Austria (1) · Belgium (1) · France (1) · India (1) · Mexico (1) · Netherlands (1) · United Kingdom (1)
Adrian V Hill, DPhill FRCP (1) · Carlos Fierro, MD (1) · Grace Chen, MD (1) · Julie E Ledgerwood, D.O. (1) · Julie E Ledgerwood, DO (1) · Krishna Mohan, PHD (1) · Nina Wressnigg (1) · Sascha Goonewardena, MD (1)
PMID 25132507, PMID 27206386, PMID 32497524, PMID 34330906, PMID 34887572, PMID 35210606, PMID 35568049, PMID 38494412
2014 (1), U44AI152995 (1)